In previous work on the KCNH2 variant p.Gly584Ser [13], which increases risk of long QT syndrome, and on BRCA1 p.Val1736Ala [12], we similarly identified carriers in our Northern Isles research populations who could not have been ascertained from family-based cascade testing. This evidence concerns the gene KCNH2 and Prolonged QT interval.